Creating, facilitating and promoting sustainable Health Technology Assessment (HTA) cooperation in Europe

EUnetHTA 21

EUnetHTA 21

On 17 September 2021, the European Health and Digital Executive Agency (HaDEA) signed the Service Contract for the Provision of Joint Health Technology Assessment (HTA) Work

Read More »

COVID-19 Response

EUnetHTA has prioritised COVID-19-related initiatives above other work during the current time. Here you will find updated information and publications relating to COVID-19 diagnostic testing, therapeutic treatments, and useful links to further data from our network partners.

Services

EUnetHTA develops several services that help inform the decision-making process around the introduction of pharmaceuticals and other technologies at the national, regional, and European levels. These include Joint Assessments, Early Dialogues, and Post Launch Evidence Generation (PLEG). Find out more here.

Assessments

Pharmaceutical Joint Assessments (PTJA) and Other Technologies Collaborative Assessments (OTCA) are key EUnetHTA outputs. Find current project status, EUnetHTA Prioritisation List (EPL) and Topic Identification, Selection, and Prioritisation (TISP), uptake data and archived content here.

Tools

EUnetHTA has developed a suite of tools to complement all steps in the collaborative joint work process, helping partners to proceed with a defined methodology. Access all current and archived tools here.

Get Involved

EUnetHTA functions as a collaboration between network members and exterior partners to develop joint work. These include patients, industry, regulators, HCPs, and payers. Find out more about partner involvement, activities, and EUnetHTA events here.

Have questions? Check our FAQ